KEIO PLAZA HOTEL TOKYO HOSTS EXHIBITION OF SPECTACULAR IKEBANA FLOWER ARRANGEMENT BY ARTIST HIROKI MAENO

Decorating Lobby with Beautiful "Sakura" Cherry Blossoms

TOKYO, March 21 (Bernama-BUSINESS WIRE) -- Keio Plaza Hotel Tokyo, one of Japan's most prestigious international hotels located in Shinjuku, Tokyo, will host a special exhibition of "Ikebana" flower arrangement created by the renowned artist Hiroki Maeno from April 1 to 16, 2017. A large 2.7 by 5 meter flower arrangement lavishly adorned with some 200 beautiful "sakura" cherry blossom branches, which are one of the most symbolically important representatives of the Japanese aesthetic beauty during the spring, will be displayed in the third floor main lobby area for hotel guests to enjoy free of charge.

The artist Hiroki Maeno will also provide two Ikebana flower arrangement workshops held on April 6 from 4:00p.m. and 6:30p.m. in front of his beautiful arrangement. Guests will be able to view these workshops as they will be held in the lobby area.

http://mrem.bernama.com/viewsm.php?idm=28721

AMENDED SUMMARY NOTICE OF PROPOSED SETTLEMENT OF THE ALTAIR NANOTECHNOLOGIES, INC. SHAREHOLDER DERIVATIVE LITIGATION

UNITED STATES DISTRICT COURT

SOUTHERN DISTRICT OF NEW YORK

In re Altair Nanotechnologies Shareholder Derivative Litigation CASE NO.: 14-CV-09418-TPG-HBP

RENO, Nev., March 20 (Bernama-GLOBE NEWSWIRE) -- PLEASE BE ADVISED that Plaintiffs and the Settling Defendants have reached a settlement (the “Settlement”) to resolve the issues raised in the above-captioned consolidated derivative action (“Action”) (capitalized terms are defined in the Stipulation of Settlement dated July 22, 2016, and Amendment No. 1 to the Stipulation, dated January 18, 2017 (collectively, the “Settlement Stipulation”)).

PLEASE BE FURTHER ADVISED that pursuant to an Order of the United States District Court for the Southern District of New York (the “Court”), a hearing (the “Settlement Hearing”) will be held before the Honorable Thomas P. Griesa in the United States District Court for the Southern District of New York, 500 Pearl Street, Courtroom 26B, New York, New York 10007, at 2:00 p.m. on August 10, 2017, to determine whether (i) the proposed settlement should be approved by the Court as fair, reasonable, adequate, and in the best interests of Altair Nanotechnologies, Inc. (“Altair” or the “Company”) and Altair shareholders; (ii) the Action should be dismissed with prejudice and all Released Claims against the Released Persons should be released and extinguished; (iii) the Court should award attorneys’ fees and expenses to Plaintiffs’ Counsel and incentive awards to Plaintiffs; and (iv) to consider such other matters as may properly come before the Court. The Settlement Hearing may be continued by the Court at the Settlement Hearing, or at any adjourned session thereof without further notice.  The Action and Settlement address claims alleging that certain current and former directors and officers of Altair breached their fiduciary duties by failing to implement and/or maintain adequate internal controls over the Company’s operations and disclosures, by making or approving false statements to the Company’s shareholders, by grossly mismanaging the Company, and by wasting Altair’s assets by causing the Company to incur significant potential liability for legal costs, penalties, fines and/or legal fees in connection with the defense of the Individual Defendants’ unlawful course of conduct. The Action further alleges that certain Defendants were unjustly enriched at the Company’s expense. The Settling Defendants deny and continue to deny all allegations of wrongdoing and deny that Defendants have any liability on the claims asserted in the Action.

As part of the Settlement, Altair has agreed to adopt and/or maintain certain corporate governance reforms as set forth in the Settlement Stipulation. The terms and conditions of the proposed Settlement are set forth in the Settlement Stipulation and Addendum thereto. The Settlement Stipulation and amended Exhibits thereto have been filed with the Court.

Plaintiffs’ Counsel will request Court approval of the agreed upon attorneys’ fees and expenses in an amount not to exceed $150,000, which shall include all attorneys’ fees and costs that may be due any counsel (or anyone else) who has asserted, or participated in the assertion of, derivative claims on behalf of Altair in any court. Any award of fees and expenses will be paid by the Company (or its insurer on its behalf). To date, Plaintiffs’ Counsel have neither received any payment for their services in conducting the Action, nor have counsel been reimbursed for their out-of-pocket expenses incurred. Plaintiffs will also seek Court approval of an incentive payment of up to $1,500 each for their participation and efforts in the Action. This Incentive Amount shall be paid from the attorneys’ fees and expenses awarded by the Court. If the Settlement is approved, the Action will be dismissed with prejudice and the Defendants will be released by Plaintiffs, Altair, and its shareholders from all claims that were or could have been alleged in the Action.

http://mrem.bernama.com/viewsm.php?idm=28716

ZEROSTACK OPENS ASIA/PACIFIC REGION WITH M5 TECHNOLOGIES

Singapore region positioned for strong private cloud growth

MOUNTAIN VIEW, Calif., March 20 (Bernama-BUSINESS WIRE) -- ZeroStack, Inc., the leader in making self-driving private cloud affordable for all companies, today announced that it has signed a reseller agreement with M5 Technologies, an IT infrastructure expert headquartered in Singapore, adept at both traditional and cutting edge technologies, with activities currently spanning and increasing across Asia South.

"Our region is going through a rapid economic shift to cloud services, requiring on-premises options that can also be integrated with local hosting, managed services providers and public cloud providers," said Joel Norton, ZeroStack's Regional Manager Asia South at M5 Technologies and assigned to positioning ZeroStack's cloud platform. "This service delivery landscape is an ideal opportunity for M5 to position ZeroStack's leading integrated solutions as fundamental and foundational to a business' digital transformation."

http://mrem.bernama.com/viewsm.php?idm=28717

JNTO LAUNCHES "JAPAN INCENTIVES" WEBSITE IN 4 LANGUAGES TO SHOWCASE JAPAN'S APPEAL AS MICE DESTINATION

TOKYO, March 21 (Bernama-AsiaNet) -- The Japan National Tourism Organization's (JNTO) has launched a specialized website for Japan incentives, featuring information on incentives in the country. The incentives site is hosted within JNTO's Japan MEETINGS & INCENTIVES website for promoting MICE (meetings, incentives, conventions and exhibitions/events).

(Image: http://prw.kyodonews.jp/opn/release/201703169999/?images)

http://mrem.bernama.com/viewsm.php?idm=28733

TOMI ENVIRONMENTAL SOLUTIONS, INC. COMPLETES $5.3 MILLION PRIVATE PLACEMENT FUNDING LED BY INSTITUTIONAL FUNDS BASED IN HONG KONG

BEVERLY HILLS, Calif., March 21 (Bernama-GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ), a global decontamination and infection prevention company that specializes in disinfection/decontamination sales and services, including the manufacturing, sale and licensing of its SteraMist^™, a hydrogen peroxide-based mist/fog that is registered with the U.S. Environmental Protection Agency (“EPA”), announced today that it raised gross proceeds of $5.3 million in a private placement transaction (the “Financing”). TOMI will use the proceeds from the Financing for research and development, international product registration, expansion of its internal sales force, marketing, public relations, expansions of its EPA label and for working capital and general corporate purposes.

http://mrem.bernama.com/viewsm.php?idm=28723

A.M. BEST AFFIRMS CREDIT RATINGS OF STARR PROPERTY & CASUALTY INSURANCE (CHINA) COMPANY, LIMITED

HONG KONG, March 17 (Bernama-BUSINESS WIRE) -- A.M. Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of "a" of Starr Property & Casualty Insurance (China) Company, Limited (Starr China) (China). The outlook of these Credit Ratings (ratings) is stable.

The rating affirmations reflect Starr China's supportive risk-adjusted capitalization under a strengthened surplus position, and an improved operating expense ratio. In addition, Starr China receives business and operational support from Starr International Company, Inc. (SICO) and its insurance subsidiaries, as well as a capital commitment from Starr Insurance & Reinsurance Limited (SIRL), a company within SICO that is a 20% shareholder of Starr China. Starr China also assumes overseas treaty business ceded from the group, which has accounted for a substantial portion of the company's total gross premiums written since 2015.

http://mrem.bernama.com/viewsm.php?idm=28706

SUNWAY MEDICAL CENTRE LAUNCHES 'IORT' TO FIGHT CANCER

     

KUALA LUMPUR, March 17 (Bernama) -- The Sunway Medical Centre (SunMed), a

leader in Cancer treatment and care recently launched the Intraoperative

Radiation Therapy System (IORT), an innovative tool in fighting against cancer.

SunMed in a statement today stated the launch of IORT treatment was an

initiative to provide the quality of patient-centered coordinated care for those

undergoing cancer treatment and therapy in Malaysia.

The breakthrough method allows patients to undergo a one-time radiaton

treatment, which is delivered in a single, targeted dose during surgery itself,

and unlike standard radiation treatment as little damage as possible to normal

tissue around where the tumor used to be.

"Despite recent advances, there remains an urgent need for innovative and

effective treatment options for cancer patients in Malaysia. With IORT, SunMed

hopes to provide the patients cutting edge treatment options coupled with expert

services," the statement said.

The statement said the IORT was meant to put less stress on patients'

skin and organs while giving them peace of mind that they could complete

treatment as quickly as possible and return to the family and daily life.

    -- BERNAMA